Mujie J. Ye

No. 300 Guangzhou Road
Nanjing, 210029, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 52 publications

Effect and mechanism of chloroquine on supressing the growth of pancreatic neuroendocrine tumors

Effect and mechanism of chloroquine on supressing the growth of pancreatic neuroendocrine tumors

Journal: Zhonghua yi xue za zhi

Published: August 19, 2026

Analysis of clinical and pathological characteristics and prognostic factors in patients with pancreatic neuroendocrine neoplasms

Analysis of clinical and pathological characteristics and prognostic factors in patients with pancreatic neuroendocrine neoplasms

Journal: Zhonghua yi xue za zhi

Published: August 19, 2026

A Novel Bruton's Tyrosine Kinase Inhibitor Suppresses Pancreatic Neuroendocrine Neoplasms Progression via ATF3-Induced Ferroptosis.

A Novel Bruton's Tyrosine Kinase Inhibitor Suppresses Pancreatic Neuroendocrine Neoplasms Progression via ATF3-Induced Ferroptosis.

Journal: Cancers

Published: June 01, 2026

Serum Carcinoembryonic Antigen, Carbohydrate Antigen, Neuron-specific Enolase and Lipid Profile to Predict the Occurrence, Pathological Grading and Metastasis of Pancreatic Neuroendocrine Tumors.

Serum Carcinoembryonic Antigen, Carbohydrate Antigen, Neuron-specific Enolase and Lipid Profile to Predict the Occurrence, Pathological Grading and Metastasis of Pancreatic Neuroendocrine Tumors.

Journal: Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association

Published: May 18, 2026

Erratum: FTO-induced APOE promotes the malignant progression of pancreatic neuroendocrine neoplasms through FASN-mediated lipid metabolism: Erratum.

Erratum: FTO-induced APOE promotes the malignant progression of pancreatic neuroendocrine neoplasms through FASN-mediated lipid metabolism: Erratum.

Journal: International journal of biological sciences

Published: April 20, 2026

Machine learning models to predict the recurrence of common bile duct stones after ERCP.

Machine learning models to predict the recurrence of common bile duct stones after ERCP.

Journal: BMC gastroenterology

Published: April 13, 2026

HMGCS1 as a potential mediator of resistance to EZH2 inhibition via ferroptosis mediated by PI3K/AKT/mTOR pathway in the pancreatic neuroendocrine neoplasms.

HMGCS1 as a potential mediator of resistance to EZH2 inhibition via ferroptosis mediated by PI3K/AKT/mTOR pathway in the pancreatic neuroendocrine neoplasms.

Journal: Endocrine-related cancer

Published: November 18, 2025

Orlistat combined with everolimus suppresses pancreatic neuroendocrine tumor progression via inhibiting PI3K/AKT/mTOR signaling mediated by SLFN5.

Orlistat combined with everolimus suppresses pancreatic neuroendocrine tumor progression via inhibiting PI3K/AKT/mTOR signaling mediated by SLFN5.

Journal: Endocrine-related cancer

Published: October 16, 2025

A Viscosity-Responsive Mitochondria-Targeting Ir(III) Probe for Inducing and Monitoring Photodynamic-Triggered Ferroptosis.

A Viscosity-Responsive Mitochondria-Targeting Ir(III) Probe for Inducing and Monitoring Photodynamic-Triggered Ferroptosis.

Journal: Journal of medicinal chemistry

Published: August 05, 2025

TGFBI deficiency facilitates tumor associated macrophages M2 polarization and angiogenesis to promote pancreatic neuroendocrine neoplasms progression.

TGFBI deficiency facilitates tumor associated macrophages M2 polarization and angiogenesis to promote pancreatic neuroendocrine neoplasms progression.

Journal: Cancer cell international

Published: July 03, 2025

Synergistic Anti-Tumor Effects of Sulfatinib and Kaempferol on Pancreatic Neuroendocrine Tumors via CALCA-mediated PI3K/AKT/mTOR Pathway.

Synergistic Anti-Tumor Effects of Sulfatinib and Kaempferol on Pancreatic Neuroendocrine Tumors via CALCA-mediated PI3K/AKT/mTOR Pathway.

Journal: International journal of biological sciences

Published: June 08, 2025

Identification of A-to-I RNA editing profiles and their clinical relevance in pancreatic neuroendocrine neoplasms.

Identification of A-to-I RNA editing profiles and their clinical relevance in pancreatic neuroendocrine neoplasms.

Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]

Published: May 20, 2025

Showing 1-12 of 52

Last Updated: 09/26/2026